Monopar Therapeutics (MNPR) Return on Assets [ROA] (2018 - 2026)
Monopar Therapeutics' Return on Assets [ROA] came in at -10.06% for Q2 2026, up 5.12 percentage points from -15.18% a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2025, Monopar Therapeutics' Return on Assets [ROA] was -13.65%, up 32.44 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +29.43 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -46.09% in FY2024 (+35.60 pp), -81.69% in FY2023 (-19.24 pp), -62.45% in FY2022 (-13.63 pp) and -48.82% in FY2021 (-5.75 pp).
- The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] in data going back to Q1 2018.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2025 (a gain of 91.71 percentage points), and the weakest in Q3 2023 (a drop of 36.52 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Monopar Therapeutics | 666.05 Mn | 384.28 Mn | - | -10.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.06% |
| Sep 30, 2025 | -10.09% |
| Jun 30, 2025 | -15.18% |
| Mar 31, 2025 | -12.93% |
| Sep 30, 2024 | -101.80% |
| Jun 30, 2024 | -89.76% |
| Mar 31, 2024 | -96.39% |
| Dec 31, 2023 | -109.41% |
| Sep 30, 2023 | -102.64% |
| Jun 30, 2023 | -91.74% |
| Mar 31, 2023 | -84.64% |
| Dec 31, 2022 | -76.16% |
| Sep 30, 2022 | -66.12% |
| Jun 30, 2022 | -59.54% |
| Mar 31, 2022 | -50.22% |
| Dec 31, 2021 | -42.41% |
| Sep 30, 2021 | -37.07% |
| Jun 30, 2021 | -31.36% |
| Mar 31, 2021 | -33.98% |
| Dec 31, 2020 | -37.17% |
API Access
Monopar Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();